This company has been marked as potentially delisted and may not be actively trading. Cyanotech (CYAN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsBuy This Stock CYAN vs. HAPP, BON, SMFL, PTHL, IMCC, BFRI, PHXM, BNGO, SONN, and LIXTShould you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), Bon Natural Life (BON), Smart for Life (SMFL), Pheton (PTHL), IM Cannabis (IMCC), Biofrontera (BFRI), PHAXIAM Therapeutics (PHXM), Bionano Genomics (BNGO), Sonnet BioTherapeutics (SONN), and Lixte Biotechnology (LIXT). Cyanotech vs. Its Competitors Happiness Development Group Bon Natural Life Smart for Life Pheton IM Cannabis Biofrontera PHAXIAM Therapeutics Bionano Genomics Sonnet BioTherapeutics Lixte Biotechnology Cyanotech (NASDAQ:CYAN) and Happiness Development Group (NASDAQ:HAPP) are both small-cap medicinals & botanicals industry companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends. Is CYAN or HAPP more profitable? Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.Company Net Margins Return on Equity Return on Assets Cyanotech-19.50% -44.71% -19.12% Happiness Development Group N/A N/A N/A Which has stronger valuation & earnings, CYAN or HAPP? Cyanotech has higher earnings, but lower revenue than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCyanotech$23.07M0.11-$5.27M-$0.66-0.56Happiness Development Group$95.59M0.06-$49.19M$0.481.63 Which has more volatility and risk, CYAN or HAPP? Cyanotech has a beta of -0.11, suggesting that its stock price is 111% less volatile than the S&P 500. Comparatively, Happiness Development Group has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Does the media prefer CYAN or HAPP? In the previous week, Cyanotech had 1 more articles in the media than Happiness Development Group. MarketBeat recorded 1 mentions for Cyanotech and 0 mentions for Happiness Development Group. Cyanotech's average media sentiment score of 0.00 equaled Happiness Development Group'saverage media sentiment score. Company Overall Sentiment Cyanotech Neutral Happiness Development Group Neutral Do insiders and institutionals have more ownership in CYAN or HAPP? 24.4% of Cyanotech shares are held by institutional investors. Comparatively, 15.2% of Happiness Development Group shares are held by institutional investors. 29.1% of Cyanotech shares are held by insiders. Comparatively, 15.6% of Happiness Development Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryHappiness Development Group beats Cyanotech on 7 of the 12 factors compared between the two stocks. Get Cyanotech News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYAN vs. The Competition Export to ExcelMetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.65M$3.44B$5.47B$9.53BDividend YieldN/AN/A4.74%4.08%P/E Ratio-0.567.6328.6723.80Price / Sales0.1127.08422.3188.12Price / CashN/A5.6235.4557.96Price / Book0.281.108.275.55Net Income-$5.27M$17.44M$3.24B$259.03M Cyanotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYANCyanotech0.8616 of 5 stars$0.37flatN/A-47.3%$2.65M$23.07M-0.5695Short Interest ↓Gap UpHAPPHappiness Development GroupN/A$0.78-11.0%N/A-20.1%$5.45M$95.59M1.63215Gap DownBONBon Natural LifeN/A$1.37-2.1%N/A-97.6%$229K$23.84M0.00100Gap DownSMFLSmart for LifeN/A$0.00-90.5%N/A-99.8%$16K$11.11M0.00110Gap DownHigh Trading VolumePTHLPhetonN/A$1.65-94.7%N/AN/A$10.86M$448.20K0.0011News CoveragePositive NewsHigh Trading VolumeIMCCIM Cannabis0.2698 of 5 stars$2.67-4.6%N/A-14.2%$10.79M$39.44M-4.17340News CoverageBFRIBiofrontera1.6738 of 5 stars$1.05-1.9%$2.75+161.9%-8.0%$10.65M$37.32M-0.4670Gap UpPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58MN/A0.0049BNGOBionano Genomics1.3925 of 5 stars$3.08-5.8%$7.00+127.3%-91.6%$10.36M$28.46M-0.02300News CoveragePositive NewsUpcoming EarningsSONNSonnet BioTherapeutics2.143 of 5 stars$3.26-19.5%$20.00+513.5%-55.5%$10.32M$1M0.0010Short Interest ↑Gap DownLIXTLixte Biotechnology0.3334 of 5 stars$3.83-5.9%N/A+119.9%$10.28MN/A-2.644Upcoming Earnings Related Companies and Tools Related Companies HAPP Competitors BON Competitors SMFL Competitors PTHL Competitors IMCC Competitors BFRI Competitors PHXM Competitors BNGO Competitors SONN Competitors LIXT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYAN) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
